News

Article

NeurologyLive® Friday 5 — February 17, 2023

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 17, 2023.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Top News for International Epilepsy Day

For International Epilepsy Day— February 14, 2023—the team has culminated some of the biggest pieces of news and insightful exchanges with physicians to offer updates on new developments in literature and expert opinions about stroke to spread awareness on the prevention and treatment of the condition.

Top News for International Epilepsy Day

2: Peer Exchange: Management Based on Type of Spinal Muscular Atrophy, Patient Needs, and Age

In episode 10 of this Peer Exchange, the panel of experts in neurology consider best practices for management based on the type of spinal muscular atrophy, age, and the therapy received. The NeurologyLive® series panel features Juliana Gurgel Giannetti, PhD, Rodrigo de Holanda Mendonça, MD, and Adriana Banzzatto Ortega, MD.

Management Based on Type of Spinal Muscular Atrophy, Patient Needs, and Age

3: NeuroVoices: Ronald C. Peterson, MD, PhD, on Redefining Clinically Meaningful Benefit in Alzheimer Drug Development

In the latest edition of our in-depth Q&A series, the director of the Alzheimer’s Disease Research Center at Mayo Clinic provided insight on new considerations for interpreting data from cognitive and functional measures in trials assessing agents for Alzheimer disease. He discussed the complexities of identifying clinically meaningful benefit, potential for adaptive trials, and the lessons learned from antiamyloid therapies like aducanumab and lecanemab.

NeuroVoices: Ronald C. Peterson, MD, PhD, on Redefining Clinically Meaningful Benefit in Alzheimer Drug Development

4: Clinician Perspectives on Black History Month: Jon Cokley, PharmD, BCPPS

As one of few African American males focusing on pediatric epilepsy research, Jon A. Cokley, PharmD, BCPPS, a pediatric neurology clinical pharmacy specialist at Texas Children’s Hospital and a neurology instructor at Baylor College of Medicine, hopes his work can help increase awareness, and address biases that exist in healthcare and hopes to help foster a dialogue that can be more inclusive for the benefit of patients living with epilepsy.

Clinician Perspectives on Black History Month: Jon Cokley, PharmD, BCPPS

5: The Science of Sleep Health and Romantic Relationships: Wendy Troxel, PhD

For Valentine’s Day, the senior behavioral scientist at the RAND Corporation sat down with NeurologyLive® in an interview to discuss the motivations behind writing her book, “Sharing the Covers – A Couple’s Guide for Better Sleep”. Based on her previous research, she shared her clinical perspective of what is currently known about sleep health in relation to the health of a romantic relationship.[WATCH TIME: 5 minutes]

The Science of Sleep Health and Romantic Relationships: Wendy Troxel, PhD
Related Videos
Gil Rabinovici, MD
MaryAnn Mays, MD
Henri Ford, MD, MHA
Michael Levy, MD, PhD, is featured in this series.
David A. Hafler, MD, FANA
© 2024 MJH Life Sciences

All rights reserved.